We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Offers $4.5 Billion for Full Control of Chiron
Novartis Offers $4.5 Billion for Full Control of Chiron
September 1, 2005
Looking to make another big splash on the acquisitions front, Novartis has offered $4.5 billion in cash for the remaining shares of California-based vaccine maker Chiron.